Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 9/30/2016 | 6/30/2016 | 9/30/2006 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $76 | $76 | $76 | $0 |
| Gross Profit | -$76 | -$76 | -$76 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $38 | $38 | $39 | $146 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$3 |
| Operating Expenses | $38 | $38 | $39 | $143 |
| Operating Income | -$114 | -$114 | -$116 | -$143 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$6 | -$6 | -$6 | $143 |
| Pre-Tax Income | -$120 | -$120 | -$121 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$120 | -$248 | -$121 | -$152 |
| % Margin | – | – | – | – |
| EPS | -0 | -0 | -0 | -1 |
| % Growth | 51.6% | -103.1% | 100% | – |
| EPS Diluted | -0 | -0 | -0 | -1 |
| Weighted Avg Shares Out | 576,965 | 577,965 | 574,965 | 269 |
| Weighted Avg Shares Out Dil | 576,965 | 577,965 | 574,965 | 269 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $6 | $6 | $0 |
| Depreciation & Amortization | $4 | $4 | $4 | $0 |
| EBITDA | -$110 | -$110 | -$112 | -$142 |
| % Margin | – | – | – | – |